查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1654644

全球介入影像市场 - 2025 - 2033

Global Interventional Imaging Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 167 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024 年全球介入影像市场规模达到 92.1 亿美元，预计到 2033 年将达到 166.4 亿美元，2025-2033 年预测期内的复合年增长率为 6.8%。

介入影像是指利用先进的影像技术来引导和辅助微创手术或介入。它涉及即时成像技术，以便在医疗过程中可视化身体内部结构，使医疗专业人员能够高精度、准确地执行程序。介入影像可以在手术过程中对目标区域（例如血管、器官或组织）进行连续、即时的可视化。这对于确保正确放置器械和最大限度地减少对周围组织的伤害至关重要。

受人们对微创手术的偏好不断增加、慢性病盛行率不断上升以及技术进步日益加快的推动，介入影像市场正在经历显着增长。例如，2024 年 6 月，GE HealthCare 和 MediView XR Inc. 发布了 OmnifyXR 介入套件的第一个安装。它将即时传输医学影像的全像平视显示器与三维（3D）解剖模型视觉化和强大的成像技术相结合。它能够透过远端合作，透过广泛的干预技术提供精准护理。

市场动态：

驱动因素与约束因素

科技进步日新月异

不断增长的技术进步极大地推动了介入影像市场的成长，并有望在预测期内透过提高微创手术的准确性、速度和安全性来推动市场的发展。人工智慧正在透过改善视觉化、影像分析、即时决策和预测模型来改变介入成像。人工智慧演算法可以从影像资料中快速识别肿瘤或阻塞等异常情况，帮助临床医生做出更快、更准确的决策。

例如，2024 年 12 月，荷兰皇家飞利浦公司宣布，新推出的 CT 5300 系统透过人工智慧和智慧工作流程自动化功能增强了人们对临床决策支援的信心。飞利浦 CT 5300 结合创新的硬体、软体和人工智慧，为更多患者提供高品质的筛检和介入成像，包括透过自动化人工智慧的飞利浦高级视觉化工作区应用程式提供阅读支援。

此外，3D 和 4D 成像可提供身体结构的即时高解析度视图，有助于介入期间的精确导航。这项技术对于指导血管成形术、活检和肿瘤消融等手术至关重要。 3D 和 4D 影像的采用预计将迅速增加，从而促进市场成长，尤其是在北美和欧洲等医疗保健基础设施高度发展的地区。

例如，2024年8月，西门子医疗宣布，具有人工智慧（AI）特性的新型专用心血管超音波系统ACUSON Origin已获得FDA批准。这些特质可以帮助医生更有效地执行心臟手术，例如诊断、结构性心臟病和电生理学。新型 AcuNav Lumos 4D ICE（心内超音波心动图）导管仅与 ACUSON Origin 相容，能够改善困难心臟手术的影像效果。

严格的监管框架

严格的监管框架对介入影像市场的成长构成了重大挑战，因为它会造成延误、增加成本并限制采用新技术的速度。美国 FDA（食品药物管理局）和欧洲药品管理局（EMA）等监管机构对医疗器材（包括介入影像系统）实施了严格的审批流程。这些过程通常涉及大量临床试验、文件和审查，之后产品才能进入市场。

不同地区的医疗器材监管标准差异很大。这些差异使介入影像公司的全球市场策略变得复杂，因为它们必须遵守每个地区不同的审批流程和认证要求（例如美国的 FDA、欧洲的 CE 标誌和澳洲的 TGA）。

例如，由于安全性和功效标准的差异，FDA 批准的产品可能无法立即在欧盟或亚洲销售。这需要额外的测试和认证，这可能会延迟进入市场并增加营运的复杂性。这些地区监管差异为试图在全球扩张的公司製造了障碍，并减缓了不合规地区市场的成长，限制了他们获得最新技术的管道。

目录

第一章：市场介绍和范围

  • 报告目标
  • 报告范围和定义
  • 报告范围

第 2 章：高阶主管见解与关键要点

  • 市场亮点和战略要点
  • 主要趋势和未来预测
  • 按产品类型分类的片段
  • 影像方式片段
  • 按应用程式截取的程式码片段
  • 按过程类型分类的程式码片段
  • 最终用户的程式码片段
  • 按地区分类的片段

第 3 章：动态

  • 影响因素
    • 驱动程式
      • 不断进步的技术
    • 限制
      • 严格的监管框架
    • 机会
    • 影响分析

第四章：战略洞察与产业展望

  • 市场领导者和先驱者
    • 新兴先锋和杰出参与者
    • 拥有最大销售品牌的成熟领导者
    • 拥有成熟产品的市场领导者
  • 新兴创业公司和关键创新者
  • CXO 观点
  • 最新进展与突破
  • 案例研究/正在进行的研究
  • 监管和报销情况
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 波特五力分析
  • 供应链分析
  • 专利分析
  • SWOT 分析
  • 未满足的需求和差距
  • 市场进入和扩张的推荐策略
  • 情境分析：最佳情况、基本情况和最坏情况预测
  • 定价分析和价格动态

第 5 章：介入性影像市场（依产品类型）

  • 介入性影像系统
    • MRI 系统
    • 超音波成像系统
    • CT 扫描仪
    • 血管摄影系统
    • 其他的
  • 介入影像配件
    • X 射线侦测器
    • C 臂
    • 影像增强器
  • 软体
  • 耗材
    • 导管
    • 导丝
    • 针
    • 其他的

第 6 章：介入性影像市场（以影像方式划分）

  • X 光影像
  • 电脑断层扫描 (CT)
  • 磁振造影（MRI）
  • 超音波成像
  • 其他的

第 7 章：介入性影像市场（按应用）

  • 心臟病学
  • 肿瘤学
  • 神经病学
  • 泌尿科和肾臟科
  • 胃肠病学
  • 肌肉骨骼
  • 其他的

第 8 章：介入性影像市场（依手术类型）

  • 诊断程序
  • 治疗程序

第 9 章：介入性影像市场（依最终用户划分）

  • 医院
  • 专科诊所
  • 诊断中心
  • 门诊手术中心
  • 其他的

第 10 章：介入性影像市场，按区域市场分析和成长机会

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲

第 11 章：竞争格局与市场定位

  • 竞争概况和主要市场参与者
  • 市占率分析与定位矩阵
  • 策略伙伴关係、併购
  • 产品组合和创新的关键发展
  • 公司基准化分析

第 12 章：公司简介

  • GE HealthCare
    • 公司概况
    • 产品组合和描述
    • 财务概览
    • 关键进展
    • SWOT 分析
  • Koninklijke Philips NV
  • Siemens Healthineers AG
  • CANON MEDICAL SYSTEMS USA, INC.
  • FUJIFILM Holdings Corporation
  • Lumibird Medical
  • Boston Scientific Corporation
  • Terumo Corporation
  • Guerbet
  • Shimadzu Corporation

第 13 章：假设与研究方法

  • 资料收集方法
  • 数据三角测量
  • 预测技术
  • 数据验证和确认

第 14 章：附录

简介目录
Product Code: MI9090

The global interventional imaging market reached US$ 9.21 billion in 2024 and is expected to reach US$ 16.64 billion by 2033, growing at a CAGR of 6.8% during the forecast period 2025-2033.

Interventional imaging refers to the use of advanced imaging techniques to guide and assist minimally invasive procedures or interventions. It involves real-time imaging technology to visualize internal structures of the body during medical treatments, enabling healthcare professionals to perform procedures with high precision and accuracy. Interventional imaging provides continuous, real-time visualization of the target area, such as blood vessels, organs, or tissues, during a procedure. This is essential for ensuring the correct placement of instruments and minimizing damage to surrounding tissues.

The interventional imaging market is experiencing significant growth, driven by a rising preference for minimally invasive procedures, a rising prevalence of chronic diseases and increasing technological advancements. For instance, in June 2024, GE HealthCare and MediView XR Inc. released the first installation of the OmnifyXR interventional suite. It combines a holographic heads-up display that streams real-time medical images with three-dimensional (3D) anatomical model visualization and powerful imaging technology. It enables remote cooperation for the delivery of precision care across a wide range of intervention techniques.

Market Dynamics: Drivers & Restraints

Rising technological advancements

The rising technological advancements are significantly driving the growth of the interventional imaging market and are expected to drive the market over the forecast period by enhancing the accuracy, speed, and safety of minimally invasive procedures. Artificial intelligence is transforming interventional imaging by improving visualization, image analysis, real-time decision-making, and predictive modeling. AI algorithms can quickly identify abnormalities, such as tumors or blockages, from imaging data, helping clinicians make faster, more accurate decisions.

For instance, in December 2024, Royal Philips announced a boost in confidence in clinical decision support with AI and smart workflow automation capabilities in the recently introduced CT 5300 system. Philips CT 5300 combines innovative hardware, software and artificial intelligence for high-quality screening, and interventional imaging accessible to more patients, including reading support with Automated AI-enabled Philips Advanced Visualization Workspace applications.

Additionally, 3D and 4D imaging provide real-time, high-resolution views of the body's structures, aiding in precise navigation during interventions. This technology is crucial for guiding procedures like angioplasty, biopsy, and tumor ablation. The adoption of 3D and 4D imaging is expected to increase rapidly, contributing to market growth, especially in regions with high healthcare infrastructure, like North America and Europe.

For instance, in August 2024, Siemens Healthineers announced that ACUSON Origin, a new specialized cardiovascular ultrasound system with artificial intelligence (AI) characteristics, has received FDA clearance. These qualities can help physicians execute cardiac operations more effectively, such as diagnostics, structural heart disease, and electrophysiology. The new AcuNav Lumos 4D ICE (intracardiac echocardiography) catheter, which is only compatible with the ACUSON Origin, enables improved imaging for difficult heart surgeries.

Strict regulatory frameworks

Strict regulatory frameworks pose a significant challenge to the growth of the interventional imaging market by creating delays, adding costs and restricting the speed at which new technologies can be adopted. Regulatory bodies, such as the FDA (Food and Drug Administration) in the U.S. and the European Medicines Agency (EMA) in Europe, impose stringent approval processes for medical devices, including interventional imaging systems. These processes often involve extensive clinical trials, documentation, and reviews before products can be introduced to the market.

Regulatory standards for medical devices vary significantly across regions. These differences complicate the global market strategy for interventional imaging companies, as they must adhere to different approval processes and certification requirements in each region (e.g., FDA in the U.S., CE marking in Europe, and TGA in Australia).

For instance, a product approved by the FDA might not be immediately eligible for sale in the EU or Asia due to differences in safety and efficacy standards. This requires additional testing and certifications, which can delay market entry and increase operational complexity. These regional regulatory discrepancies create barriers for companies trying to expand globally and slow down the growth of the market in non-compliant regions, limiting access to the latest technologies.

Segment Analysis

The global interventional imaging market is segmented based on product type, imaging modality, application, procedure type, end-user and region.

Product Type:

The interventional imaging systems segment is expected to dominate the interventional imaging market share

Interventional imaging systems such as MRI systems, ultrasound imaging systems and angiography systems provide real-time, detailed visual guidance during minimally invasive procedures, such as angioplasty, biopsy and tumor ablation. These systems are integral to ensuring precise targeting, reducing complications, and improving patient outcomes.

For instance, in cardiology, systems like GE Healthcare's fluoroscopy systems are widely used to guide procedures such as coronary angioplasty and stent placement, ensuring correct catheter positioning in real time. The demand for such procedures, which benefit from precise guidance, is increasing, positioning interventional imaging systems as the market leader.

Advanced imaging technologies, such as 3D/4D imaging, robotic-assisted systems and AI-powered diagnostic tools, are transforming interventional imaging systems, enhancing their accuracy, efficiency, and applicability. For instance, the Siemens Healthineers' ARTIS pheno system integrates 3D imaging with cutting-edge advanced robotic-assisted interventions, for multiple surgical and interventional procedures. The continuous innovation in imaging systems, such as the integration of AI for faster and more accurate imaging analysis, ensures their dominance in the interventional imaging market.

Geographical Analysis

North America is expected to hold a significant position in the interventional imaging market share

North America, particularly the United States, is home to major medical imaging companies such as GE Healthcare, Philips, and Siemens Healthineers. These companies are at the forefront of developing and commercializing new imaging technologies, including 3D/4D imaging, robotic-assisted interventions, and AI-powered imaging systems.

For instance, in November 2024, Philips Healthcare launched a limited release of the LumiGuide system, a new light-based catheter guidance system for cath labs that represents a step toward radiation-free interventional imaging. The focus of the technology is endovascular aortic procedures. LumiGuide system works exclusively with compatible Philips interventional systems such as Azurion and is the second-generation solution to use FORS. These continuous technological advancements and innovations in the region solidify North America's position as a leader in the interventional imaging market.

There is a rising preference for minimally invasive procedures in North America due to the benefits of shorter recovery times, reduced risks, and lower healthcare costs. Interventional imaging systems are essential in guiding these procedures with precision, which further drives their demand. For instance, the growing use of angioplasty and stent placement procedures for coronary artery disease (CAD) is driving the demand for advanced fluoroscopy and angiography systems in the U.S. The increasing demand for minimally invasive procedures is fueling the growth of the interventional imaging market in North America, as these systems are crucial for performing such interventions with high accuracy.

Asia-Pacific is growing at the fastest pace in the interventional imaging market

Asia-Pacific is seeing an influx of technological advancements in interventional imaging, with an increasing number of local manufacturers producing cost-effective, high-quality imaging systems. This trend is driving adoption by making interventional imaging more accessible in emerging markets. The presence of leading manufacturers such as India's Medtronic and Philips India and more affordable imaging systems are driving the growth of the interventional imaging market in the region, making advanced technologies more accessible to a broader population.

For instance, in November 2024, Philips India launched the new Azurion to expert interventionalists in cardiology, neurology, vascular medicine, and surgery in India. The new interventional system is intended to speed up neurovascular operations and assist care teams in making the correct decisions faster, treating more patients, and achieving better results. It has increased C-arm rotation and angulation. It also includes parking facilities for quick transitions from 2D to 3D imaging, comprehensive table-side control that eliminates the need to leave the sterile field, automatic beam rotation to obtain correctly oriented images for all angulations and rotations, and a new head immobilizer to support improved stroke care.

Competitive Landscape

The major global players in the interventional imaging market include GE HealthCare, Koninklijke Philips N.V., Siemens Healthineers AG, CANON MEDICAL SYSTEMS USA, INC., FUJIFILM Holdings Corporation, Lumibird Medical, Boston Scientific Corporation, Terumo Corporation, Guerbet, Shimadzu Corporation and among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global interventional imaging market report delivers a detailed analysis with 78 key tables, more than 80 visually impactful figures, and 167 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Product Type
  • 2.4. Snippet by Imaging Modality
  • 2.5. Snippet by Application
  • 2.6. Snippet by Procedure Type
  • 2.7. Snippet by End-User
  • 2.8. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Technological Advancements
    • 3.1.2. Restraints
      • 3.1.2.1. Strict Regulatory Frameworks
    • 3.1.3. Opportunity
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. Emerging Startups and Key Innovators
  • 4.3. CXO Perspectives
  • 4.4. Latest Developments and Breakthroughs
  • 4.5. Case Studies/Ongoing Research
  • 4.6. Regulatory and Reimbursement Landscape
    • 4.6.1. North America
    • 4.6.2. Europe
    • 4.6.3. Asia Pacific
    • 4.6.4. Latin America
    • 4.6.5. Middle East & Africa
  • 4.7. Porter's Five Force Analysis
  • 4.8. Supply Chain Analysis
  • 4.9. Patent Analysis
  • 4.10. SWOT Analysis
  • 4.11. Unmet Needs and Gaps
  • 4.12. Recommended Strategies for Market Entry and Expansion
  • 4.13. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.14. Pricing Analysis and Price Dynamics

5. Interventional Imaging Market, By Product Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 5.1.2. Market Attractiveness Index, By Product Type
  • 5.2. Interventional Imaging Systems*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 5.2.3. MRI Systems
    • 5.2.4. Ultrasound Imaging Systems
    • 5.2.5. CT Scanners
    • 5.2.6. Angiography Systems
    • 5.2.7. Others
  • 5.3. Interventional Imaging Accessories
    • 5.3.1. X-ray Detectors
    • 5.3.2. C-arms
    • 5.3.3. Image Intensifiers
  • 5.4. Software
  • 5.5. Consumables
    • 5.5.1. Catheters
    • 5.5.2. Guidewires
    • 5.5.3. Needles
    • 5.5.4. Others

6. Interventional Imaging Market, By Imaging Modality

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Imaging Modality
    • 6.1.2. Market Attractiveness Index, By Imaging Modality
  • 6.2. X-Ray Imaging*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Computed Tomography (CT)
  • 6.4. Magnetic Resonance Imaging (MRI)
  • 6.5. Ultrasound Imaging
  • 6.6. Others

7. Interventional Imaging Market, By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Cardiology*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Oncology
  • 7.4. Neurology
  • 7.5. Urology and Nephrology
  • 7.6. Gastroenterology
  • 7.7. Musculoskeletal
  • 7.8. Others

8. Interventional Imaging Market, By Procedure Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
    • 8.1.2. Market Attractiveness Index, By Procedure Type
  • 8.2. Diagnostic Procedure*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Therapeutic Procedure

9. Interventional Imaging Market, By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Specialty Clinics
  • 9.4. Diagnostic Centers
  • 9.5. Ambulatory Surgical Centers
  • 9.6. Others

10. Interventional Imaging Market, By Regional Market Analysis and Growth Opportunities

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Imaging Modality
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
    • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.8.1. U.S.
      • 10.2.8.2. Canada
      • 10.2.8.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Imaging Modality
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
    • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.8.1. Germany
      • 10.3.8.2. U.K.
      • 10.3.8.3. France
      • 10.3.8.4. Spain
      • 10.3.8.5. Italy
      • 10.3.8.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Imaging Modality
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
    • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.8.1. Brazil
      • 10.4.8.2. Argentina
      • 10.4.8.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Imaging Modality
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
    • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.8.1. China
      • 10.5.8.2. India
      • 10.5.8.3. Japan
      • 10.5.8.4. South Korea
      • 10.5.8.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Imaging Modality
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
    • 10.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape and Market Positioning

  • 11.1. Competitive Overview and Key Market Players
  • 11.2. Market Share Analysis and Positioning Matrix
  • 11.3. Strategic Partnerships, Mergers & Acquisitions
  • 11.4. Key Developments in Product Portfolios and Innovations
  • 11.5. Company Benchmarking

12. Company Profiles

  • 12.1. GE HealthCare*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
    • 12.1.5. SWOT Analysis
  • 12.2. Koninklijke Philips N.V.
  • 12.3. Siemens Healthineers AG
  • 12.4. CANON MEDICAL SYSTEMS USA, INC.
  • 12.5. FUJIFILM Holdings Corporation
  • 12.6. Lumibird Medical
  • 12.7. Boston Scientific Corporation
  • 12.8. Terumo Corporation
  • 12.9. Guerbet
  • 12.10. Shimadzu Corporation

LIST NOT EXHAUSTIVE

13. Assumption and Research Methodology

  • 13.1. Data Collection Methods
  • 13.2. Data Triangulation
  • 13.3. Forecasting Techniques
  • 13.4. Data Verification and Validation

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us